Completion Dissection or Observation for Sentinel-Node Metastasis in MelanomaMark B. Faries, Robert M. Elashoff, Richard Hoefer et al.|New England Journal of Medicine|2017Cited by 1.4k
Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b studyJeffrey S. Weber, Tal Zaks, Meredith McKean et al.|The Lancet|2024Cited by 729
ESMO consensus conference recommendations on the management of metastatic melanoma: under the auspices of the ESMO Guidelines CommitteeUlrich Keilholz, Olivier Michielin, P.A. Ascierto et al.|Annals of Oncology|2020Cited by 232